Gravity Diagnostics, LLC

Gravity Diagnostics, LLC operates as a laboratory that provides a diverse range of diagnostic testing services. Founded in 2007 in Covington, US, the firm has engaged in one notable deal to date. In February 2025, the company raised USD 5 mn in funding led by Advantage Capital Partners, alongside Community Development Venture Capital Alliance. Julie Brazil and Tony Remington (CEO) co-founded the firm.

Gravity Diagnostics operates as a CAP-accredited and CLIA-certified laboratory providing a range of innovative diagnostic testing services that include toxicology, pharmacogenetics, infectious diseases, upper respiratory diseases, blood testing, and COVID-19 diagnostics. The laboratory is designed to meet the high standards of healthcare providers by offering comprehensive solutions and results that facilitate informed decision-making regarding patient care. Their services are utilized by healthcare facilities, addiction treatment centers, and medical practitioners across all 50 states in the U. S.

, ensuring that they can address various diagnostic needs effectively. The end-users of these services include healthcare professionals and their patients, who benefit from accurate testing and timely results that help in managing treatment plans.   The revenue model of Gravity Diagnostics is structured around providing diagnostic testing services primarily through B2B partnerships with healthcare providers and institutions. Clients typically engage in transactions that involve ordering specific tests for their patients, which is supported by the laboratory's commitment to regulatory compliance and quality client service.

Specific pricing details are not disclosed, but the company likely offers tailored pricing plans based on the volume and type of testing services utilized, which may include bulk testing agreements or subscription models for continuous service.